Why isn't it all over the market? | CED Clinic

The idea that THCV acts as an appetite suppressant comes from early animal studies and some small-scale research suggesting it might block the receptors in the brain that signal hunger. This led many manufacturers to market it specifically for weight management, hoping it would help people eat less without feeling deprived.

However, when we look at human data, the picture is much more complicated than a simple "suppressant" label suggests. The effects of THCV appear to be dose-dependent and can vary significantly between individuals; some studies have even noted that higher doses might increase appetite rather than decrease it in certain people. Because our current understanding relies on very few high-quality human trials, we cannot confidently predict how this compound will affect any specific person's hunger signals or weight.

This uncertainty is a primary reason why THCV has not flooded the market like CBD and THC have done for consumers seeking proven results. Manufacturers are generally cautious about making strong claims that lack robust clinical backing, especially in an area as sensitive as appetite regulation where individual responses can be unpredictable.